Which Are the Principal Established or Potential Risks for Donors Undergoing Cytapheresis Procedures and How Can They Be Prevented?1

Abstract

Vox SanguinisVolume 39, Issue 3 p. 169-179 Which Are the Principal Established or Potential Risks for Donors Undergoing Cytapheresis Procedures and How Can They Be Prevented?1 Dr. H. Borberg, Dr. H. Borberg Medizinische Universitätsklinik, Joseph-Stelzmann-Strasse 9, D-5000 Köln-Lindenthal (FRG)Search for more papers by this authorMiriam B. Dahlke MD, Miriam B. Dahlke MD Medical Director, American Red Cross Blood Services, 23rd & Chestnut Streets, Philadelphia, PA 19103 (USA)Search for more papers by this authorDr. I. D. Fraser, Dr. I. D. Fraser Regional Transfusion Centre, Bristol (England)Search for more papers by this authorJ. C. Fratantoni MD, J. C. Fratantoni MD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorJ. E. French PhD, J. E. French PhD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorPaul V. Holland MD, Paul V. Holland MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorHarvey G. Klein MD, Harvey G. Klein MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorH. F. Polesky MD, H. F. Polesky MD The Minneapolis War Memorial Blood Bank, 2304 Park Avenue, Minneapolis, MN 55404 (USA)Search for more papers by this authorS. Gerald Sandler MD, S. Gerald Sandler MD Associate Director, Blood Services, Headquarters, American Red Cross, Washington, DC 20006 (USA)Search for more papers by this author Dr. H. Borberg, Dr. H. Borberg Medizinische Universitätsklinik, Joseph-Stelzmann-Strasse 9, D-5000 Köln-Lindenthal (FRG)Search for more papers by this authorMiriam B. Dahlke MD, Miriam B. Dahlke MD Medical Director, American Red Cross Blood Services, 23rd & Chestnut Streets, Philadelphia, PA 19103 (USA)Search for more papers by this authorDr. I. D. Fraser, Dr. I. D. Fraser Regional Transfusion Centre, Bristol (England)Search for more papers by this authorJ. C. Fratantoni MD, J. C. Fratantoni MD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorJ. E. French PhD, J. E. French PhD Division of Blood and Blood Products, Bureau of Biologics, Food and Drug Administration, Bethesda, MD 20205 (USA)Search for more papers by this authorPaul V. Holland MD, Paul V. Holland MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorHarvey G. Klein MD, Harvey G. Klein MD Clinical Center Blood Bank, NIH, Bethesda, MD 20205 (USA)Search for more papers by this authorH. F. Polesky MD, H. F. Polesky MD The Minneapolis War Memorial Blood Bank, 2304 Park Avenue, Minneapolis, MN 55404 (USA)Search for more papers by this authorS. Gerald Sandler MD, S. Gerald Sandler MD Associate Director, Blood Services, Headquarters, American Red Cross, Washington, DC 20006 (USA)Search for more papers by this author First published: September 1980 https://doi.org/10.1111/j.1423-0410.1980.tb01853.xCitations: 1 1 Berne, June 1980. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume39, Issue3September 1980Pages 169-179 RelatedInformation